top of page

Acerca de

HCT Cancer Immunotherapy

​Group Designation: Subgroup

Group Description

  • To improve the health and survival of children who require critical care during and following hematopoietic cell transplantation and/or cancer immunotherapies, through collaborative clinical and translational research

  • The HCT-CI Subgroup Core Values constitute the foundational principles on which the Subgroup bases its actions internally within the Subgroup and the larger PALISI membership and externally with partner organizations, industry, and the global medical community.

    • These core values guide our priorities, engagement, and response to opportunities and challenges while accomplishing the Subgroup’s mission.

    • These core values include:

  • Diversity Equity & Inclusion: The PALISI HCT-CI Subgroup is a dynamic contributor to the improvement in the health and survival of children requiring critical care support during their hematopoietic cell transplantation and/or cancer immunotherapies.

    • We will provide a protective and inclusive environment that welcomes, respects, and empowers every participant in our collaboration.

    • We will respect and incorporate the unique identities and contributions of each member.

    • We will encourage visible participation and leadership opportunities supporting Diversity, Equity, and Inclusion (DEI) within the Subgroup and PALISI in general.

    • Our members will additionally hold each other accountable for these commitments.

Connect with HCT

Contact Person: Kris Mahadeo and Courtney Rowan

Thanks for submitting!
bottom of page